Jessica Tassan
Stock Analyst at Piper Sandler
(1.06)
# 3,545
Out of 4,829 analysts
66
Total ratings
26.42%
Success rate
-10.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Maintains: Overweight | $348 → $374 | $333.46 | +12.16% | 4 | May 5, 2025 | |
| CVS CVS Health | Maintains: Overweight | $72 → $74 | $66.97 | +10.50% | 5 | Mar 21, 2025 | |
| CTEV Claritev | Maintains: Neutral | $10 → $19 | $21.67 | -12.32% | 1 | Mar 10, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $14 → $21 | $15.12 | +38.93% | 5 | Mar 4, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $13 → $12 | $7.11 | +68.78% | 6 | Feb 27, 2025 | |
| EVH Evolent Health | Reiterates: Overweight | $17 → $16 | $9.05 | +76.80% | 3 | Feb 21, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $12 → $8 | $4.13 | +93.70% | 11 | Feb 11, 2025 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $23.07 | -17.64% | 5 | Feb 5, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $31 → $33 | $25.62 | +28.81% | 5 | Jan 29, 2025 | |
| HUM Humana | Maintains: Neutral | $270 → $288 | $249.53 | +15.42% | 3 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $605 → $600 | $380.64 | +57.63% | 5 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $17.11 | +63.65% | 4 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $23 | $59.19 | -61.14% | 3 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $25.78 | +171.53% | 4 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $100 → $70 | $6.84 | +923.39% | 2 | Feb 27, 2023 |
The Cigna Group
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $333.46
Upside: +12.16%
CVS Health
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $66.97
Upside: +10.50%
Claritev
Mar 10, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $21.67
Upside: -12.32%
Alignment Healthcare
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $15.12
Upside: +38.93%
Teladoc Health
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.11
Upside: +68.78%
Evolent Health
Feb 21, 2025
Reiterates: Overweight
Price Target: $17 → $16
Current: $9.05
Upside: +76.80%
Health Catalyst
Feb 11, 2025
Maintains: Overweight
Price Target: $12 → $8
Current: $4.13
Upside: +93.70%
Premier
Feb 5, 2025
Maintains: Neutral
Price Target: $21 → $19
Current: $23.07
Upside: -17.64%
Phreesia
Jan 29, 2025
Reiterates: Overweight
Price Target: $31 → $33
Current: $25.62
Upside: +28.81%
Humana
Jan 15, 2025
Maintains: Neutral
Price Target: $270 → $288
Current: $249.53
Upside: +15.42%
Jan 2, 2025
Maintains: Overweight
Price Target: $605 → $600
Current: $380.64
Upside: +57.63%
Sep 10, 2024
Reiterates: Overweight
Price Target: $28
Current: $17.11
Upside: +63.65%
Nov 10, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $59.19
Upside: -61.14%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $25.78
Upside: +171.53%
Feb 27, 2023
Downgrades: Neutral
Price Target: $100 → $70
Current: $6.84
Upside: +923.39%